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INTRODUCTION
AntiN-methyl D-aspartate (NMDA) receptor encephalitis 
was first described in 2007 in association with 
teratoma of ovaries in women.1It was later discovered 
that anti NMDA receptor encephalitis can occur without 
association with cancer as a primary autoimmune 
disorder and can occur in men and women of all age 
groups.2 However, it is more common in younger age 
groups and women.3,4
Anti NMDA receptor encephalitis occurs due to 
autoimmunity against NR1 subunit of the NMDA 
receptor. There exists a significant overlap between 
early symptoms of anti NMDA receptor encephalitis and 
psychiatric disorders, currently, the understanding of 
symptomatology of anti NMDA receptor encephalitis 
follows a multiphase model that includes a prodromal 
phase of flu like illness followed by phase of psychiatric 
manifestations that includes paranoia, depression, 
agitation, irritability, aggression and hallucinations. The 
psychiatric phase is followed by a phase of frank 
neurological dysfunction; this phase is heralded by 
presence of clinical signs such as catatonia,seizures, 
decreasing conscious level, coma and a variety of 
movement disorders.5 A significant percentage of 
patients may also develop autonomic instability causing 
heart rate and blood pressure abnormalities and may 
cause significant morbidity and mortality.6 A study 
published by Herken and Pruss7 has included a list of 
Red flag signs and milder “yellow flag” signs that 
suggest presence of anti NMDA receptor encephalitis in 
a patient. “Yellow flag” signs include decreasing 
consciousness, catatonia, abnormal movements, focal 
signs. Red flag signs include CSF and neuroimaging 
abnormalities, Faciobrachial movements, Generalized 
seizures, and abnormal movements.
Our case reports detail a young girl who initially 
presented with behavioral abnormalities and was later 
diagnosed with anti NMDA receptor encephalitis.
CASE PRESENTATION:
Patient is a 14 years old girl who first presented 
withcomplaints of crying episodes and insomnia. 
Patient had recently resumed school 
afterayearlongphysical absence from school due to 
COVID-19 pandemic and history suggested presence of 
stress due to school and from teachers of student. She 
was started on low dose anti-depressant medications. 
She presented a few days later to Emergency 
department when her behavioural abnormalities had 
become considerably worse and she had complaints of 
worsening insomnia,hyper religiousness, extreme 
feelings of guilt and self-harm. She had no past history 
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or family history of psychiatric illness or substance 
abuse. Patient was admitted and she gradually became 
catatonic over the next three days despite treatment 
with anti-depressants and antipsychotics. New onset 
abnormal movements of her lips and chewing were 
observed one day after admission which resulted in lip 
and tongue biting. On the second day of admission 
patient developed two episodes of generalized tonic 
clonic seizures. Patient was started on antiepileptic 
medication along with antibiotics and anti-viral drugs 
and workup for possible encephalitis was started. The 
patient at that time was catatonic with rigidity and 
abnormal posturing of body. Patient’s labs showed 
normal blood counts and chemistries with moderate 
elevation of CPK which was tested after the generalized 
tonic clonic seizure.
 
Patient’s routine analysis, Culture and HSV PCR was all 
normal, making the chances of an infectious 
encephalitis low(Table 1).
Patient underwent an MRI of the brain which showed 
few small non-specific hyperintense foci on FLAIR and 
T2WI in frontal and fronto-parietal areas without any 
contrast enhancement or diffusion restriction (Figure 
1). These foci were located in white matter and 
grey-white matter junction.
Figure 1. MRI brain plain. T2 weighted (A) and FLAIR (B) 
axial images.
A and B showhigh signal foci in bifrontal and parietal 
region in white matter and grey-white matter junction.
Patient’s CSF for autoimmune encephalitis antibody 
panel was sent at the same time as other investigations 
and was reported three days later with a positive titre of 
anti NMDA receptor antibodies, at the same time her 
HSV PCR was reported as negative. Patients antiviral 
and meningitis antibiotic cover was stopped. Patient 
was started on IV methylprednisolone one gram daily 
for 5 days followed by 5 cycles of alternate day plasma 
exchanges started 5 days after stopping 
methylprednisolone because patient had mild 
improvement of symptoms, her conscious level was still 
low and she continued having seizures. Screening for 
aetiology of anti NMDA receptor encephalitis was done 
including CT scan of chest, abdomen and pelvis and 
Antinuclear Antibody testing, both of which came out 
negative. Patient was discharged on oral steroids and 
antiepileptic medications as her condition started to 
improve. On discharge the patient was fully conscious 
and takin orally but still had deficits in attention and 
memory and calculation. Patient was called for follow 
up in opd to access improvement and need for on going 
immuno suppression.
DISCUSSION:
Case reports of patients with symptoms that were later 
ascribed to anti NMDA encephalitis were published in 
1997 and 2005 in females and then the symptoms in 
all these cases resolved with removal of tumors.8 It was 
postulated in these case reports that the symptoms 
could be the result of a neoplasm associated vasculitis 
which was confirmed in 2007 by Dalmau and 
colleagues who published a case series of 12 patients 
who had antibodies to NMDA receptors on the surface 
of hippocampal neurons.  11 of the these patients had 
ovarian teratomas and improved after removal of 
tumour. To date over a 1000 cases have been 
published, It was discovered that anti NMDA receptor 
encephalitis can occur without association with cancer; 
as a primary autoimmune disorder and even though all 
age groups and genders have been 
implicated;published data shows that 80% of the 
patients were women and less than 50 years of age 
with a median age of  21.2,10Anti NMDA receptor 
encephalitis is now considered to be the second most 
common cause of autoimmune encephalitis after acute 
disseminated encephalomyelitis (ADEM). Majority of 
patients report a flu like prodromal illness with low 
grade fever, nausea, headache, myalgias, and fatigue. 
This is followed by development of psychiatric 
symptoms including delusions, hallucinations, 
paranoia, depression and self-harm.3 Most patients 
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present at this stage of illness and can be mistaken for 
acute psychosis and/or substance abuse. In general, 
the patients with anti NMDA receptor encephalitis are 
less responsive to anti-depressant and anti-psychotic 
medication for above symptoms compared to those 
with primary psychiatric diagnoses.6 The psychiatric 
symptoms evolve over days into catatonia, it is at this 
stage that the illness can mimic a neuroleptic 
malignant syndrome secondary to use of antipsychotic 
drugs. Majority of patients eventually go on to develop 
generalized seizures, prompting a neurological 
evaluation and an investigation for a possible 
encephalitis ensues.12 Abnormal facial and arm 
movements are present in a variable number of 
patients and when present are an early red flag sign to 
direct attention towards diagnosis of autoimmune 
encephalitis even before the onset of catatonia and 
seizures.
CSF analysis is the cornerstone of diagnosis of anti 
NMDA receptor encephalitis. CSF routine analysis can 
show mild pleocytosis and protein elevation. 
Oligoclonal bands can be present in CSF. CSF analysis 
for anti NMDA receptor antibody is confirmatory of 
diagnosis, the antibody can be found in serum but is 
less sensitive than CSF assay.11 All patients diagnosed 
should undergo investigations for presence of tumour 
such as an ovarian teratoma. This can be done with CT 
scans of chest and abdomen and pelvis or ultrasound 
and tumour markers. 
Treatment consists of steroids followed by 
immunotherapy with IVIG or plasma exchanges. IVIG is 
preferred in younger age group and those who have 
autonomic disturbances causing hemodynamic 
compromise during plasma exchange procedures. 
Ovarian teratomas where identified should be removed 
and their removal is associated with improvement in 
patient symptoms. Some patients with autoimmune 
anti NMDA receptor encephalitis may require use of 
second line immunotherapy with Cyclophosphamide or 
Rituximab.6 A surveillance for ovarian teratomas should 
be done for 2 years for patients who have initially tested 
negative for ovarian malignancy.
The mortality rate for acute encephalitis is around 4%, 
up to75% recover completely while the remaining have 
some neurological disability.11. Relapses are more 
common in those without teratomas. Predictors of good 
outcome include shorter time to diagnosisand timely 
initiation of treatment, admission not requiring ICU 
care, and less severe symptoms.
CONCLUSION:
Anti NMDA receptor encephalitis is an increasingly 
diagnosed cause of encephalitis associated with 
psychiatric and neurological manifestations that can be 
associated with malignancies. Because of nonspecific 
symptoms and overlapping symptoms with other 
diseases in early stages delay in diagnosis and 
treatment is common and can lead to permanent 
neurological deficits and even death. Awareness 
regarding its symptoms and signs among clinicians 
overall and neurologists specifically can lead to earlier 
diagnosis with the help of neuroimaging and CSF 
analysis for antibodies with proceeding early treatment 
leading to better outcomes. The better outcomes are 
more emphasized because a significant cohort of anti 
NMDA receptor encephalitis patients are young and 
neurological deficits can lead to lifelong disability.
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